The US government panicked!
UN Secretary General Guterres said on April 8 that after the end of the novel coronavirus pneumonia epidemic, the origin of the epidemic must be fully investigated. Donald Trump has blamed the World Health Organization for failures in the initial response to the coronavirus pandemic, even threatening to cut its funding.
The United States has been trying to avoid the origin of the novel coronavirus pneumonia epidemic. At present, the epidemic of novel coronavirus pneumonia is raging all over the world, and the United States must explain the truth to the world. The most important truth is EVALI.
THE TRUTH OF EVALI
EVALI is the name given by the US Centers for Disease Control and Prevention (CDC) to the dangerous, newly identified lung disease linked to vaping. The name EVALI is an acronym that stands for e-cigarette or vaping product use-associated lung injury. It is also known as Vaping-associated pulmonary injury (VAPI).
As we know, EVALI is not infected by known bacteria or viruses.
The important diagnosis basis of EVALI published by the US CDC is lung infiltration on chest plain radiographs or opacity of ground glass shadow on chest CT.
The symptoms of EVALI are highly consistent with novel coronavirus pneumonia.
The distribution of inpatients is similar to that of epidemics.
How does the US government prove that EVALI is not novel coronavirus pneumonia?
Actually, this is a simple question, the truth will be obtained by medical testing of patients with EVALI who are not infected with novel coronavirus.
Why did the US government strongly avoid this issue until now?
The following is EVALI case.
This photo was shared by instagram user Sunny Mangat (@drsunnyradiology) on 2019-9-13 .
The 27 year old patient presented with acute SOB and hypoxemia. The radiograph demonstrates nonspecific bibasilar patchy airspace opacities. The chest CT axial and coronal images demonstrates diffuse ground glass opacities with a bibasilar predominance.
CASE TWO October 31, 2019
Radiology: Cardiothoracic Imaging has published a special report on lung injury resulting from the use of e-cigarettes or vaping.
In the report, Authors Suhny Abbara, MD, and Fernando Uliana Kay, MD, PhD, from the Department of Radiology at UT Southwestern Medical Center in Dallas, review recent cases of e-cigarette–associated lung injury from the literature.
In one case highlighted in the report, Drs. Abbara and Kay illustrate some of the radiographic and CT findings of lung injury in the clinical case of a 24-year-old male patient with past medical history of asthma, who presented with shortness of breath, productive cough, chest pain and fever for one week. The radiologic findings included bilateral basilar predominant ground-glass and reticular opacities in both lungs. Histologic specimens obtained from the right lower lobe at biopsy were suggestive of lipoid pneumonia, according to the report. The patient was given steroids with a presumptive diagnosis of lung injury associated with e-cigarette use.
The patient reported current daily use of e-cigarettes (with tobacco) and marijuana, without substantial change in recent vaping habits. He had high white cell and platelet counts.